PBE icon

Invesco Biotechnology & Genome ETF

74 hedge funds and large institutions have $113M invested in Invesco Biotechnology & Genome ETF in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+1
Holders Change %
+1.37%
% of All Funds
2.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
19
Reduced
21
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
NCM
76
Niemann Capital Management
Nevada
-$4.09M -98,154 Closed
VF
77
Virtu Financial
New York
-$1.89M -45,444 Closed
NDSI
78
Newman Dignan & Sheerar Inc
Rhode Island
-$1.31M -31,525 Closed
Citadel Advisors
79
Citadel Advisors
Florida
-$876K -21,039 Closed
SB
80
Suntrust Banks
Georgia
-$397K -9,545 Closed
Cambridge Investment Research Advisors
81
Cambridge Investment Research Advisors
Iowa
-$280K -6,729 Closed
MCM
82
Murphy Capital Management
New Jersey
-$217K -5,220 Closed
PNC Financial Services Group
83
PNC Financial Services Group
Pennsylvania
-$42K -1,006 Closed
MA
84
MUFG Americas
New York
-$12K -296 Closed